GPRC6A
Basic information
Region (hg38): 6:116792085-116829083
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPRC6A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 48 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 48 | 4 | 4 |
Variants in GPRC6A
This is a list of pathogenic ClinVar variants found in the GPRC6A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-116792266-C-T | not specified | Uncertain significance (Jul 28, 2021) | ||
6-116792269-G-T | Benign (Aug 29, 2018) | |||
6-116792344-C-G | not specified | Uncertain significance (Aug 02, 2022) | ||
6-116792370-C-G | not specified | Uncertain significance (Jun 06, 2023) | ||
6-116792395-A-G | not specified | Likely benign (May 26, 2023) | ||
6-116792403-C-G | not specified | Uncertain significance (Jul 12, 2022) | ||
6-116792422-C-A | not specified | Uncertain significance (Feb 14, 2023) | ||
6-116792425-T-C | not specified | Uncertain significance (Aug 16, 2022) | ||
6-116792561-T-G | not specified | Uncertain significance (Jun 11, 2021) | ||
6-116792578-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
6-116792598-A-AGG | Benign (Aug 29, 2018) | |||
6-116792599-T-TA | Benign (Feb 18, 2020) | |||
6-116792602-T-TTCC | Benign (Aug 29, 2018) | |||
6-116792647-A-G | not specified | Uncertain significance (Mar 11, 2024) | ||
6-116792695-T-C | not specified | Uncertain significance (May 04, 2023) | ||
6-116792738-T-C | not specified | Likely benign (Feb 05, 2024) | ||
6-116792761-A-G | not specified | Uncertain significance (Jan 30, 2024) | ||
6-116792788-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
6-116792812-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
6-116792869-A-C | not specified | Uncertain significance (Jan 23, 2024) | ||
6-116792887-G-A | Likely benign (Aug 01, 2023) | |||
6-116792932-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
6-116793007-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
6-116793029-C-G | not specified | Uncertain significance (Jun 03, 2022) | ||
6-116793041-C-T | not specified | Uncertain significance (Sep 27, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPRC6A | protein_coding | protein_coding | ENST00000310357 | 6 | 36953 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.59e-17 | 0.0132 | 115837 | 1439 | 8464 | 125740 | 0.0402 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.178 | 473 | 484 | 0.977 | 0.0000225 | 6151 |
Missense in Polyphen | 129 | 131.07 | 0.9842 | 1745 | ||
Synonymous | 0.423 | 163 | 170 | 0.959 | 0.00000811 | 1749 |
Loss of Function | 0.301 | 26 | 27.7 | 0.938 | 0.00000127 | 374 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.648 | 0.338 |
Ashkenazi Jewish | 0.0833 | 0.0386 |
East Asian | 0.00520 | 0.00354 |
Finnish | 0.110 | 0.0492 |
European (Non-Finnish) | 0.0545 | 0.0261 |
Middle Eastern | 0.00520 | 0.00354 |
South Asian | 0.0435 | 0.0211 |
Other | 0.0736 | 0.0333 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor activated by amino acids with a preference for basic amino acids such as L-Lys, L-Arg and L-ornithine but also by small and polar amino acids. The L-alpha amino acids respond is augmented by divalent cations Ca(2+) and Mg(2+). Activated by extracellular calcium and osteocalcin. Seems to act through a G(q)/G(11) and G(i)-coupled pathway. Mediates the non-genomic effects of androgens in multiple tissue. May coordinate nutritional and hormonal anabolic signals through the sensing of extracellular amino acids, osteocalcin, divalent ions and its responsiveness to anabolic steroids. {ECO:0000269|PubMed:15576628, ECO:0000269|PubMed:20947496}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Signaling by GPCR;Signal Transduction;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0994
Intolerance Scores
- loftool
- 0.135
- rvis_EVS
- 1.63
- rvis_percentile_EVS
- 96.06
Haploinsufficiency Scores
- pHI
- 0.104
- hipred
- N
- hipred_score
- 0.219
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0298
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Gprc6a
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; liver/biliary system phenotype; skeleton phenotype; renal/urinary system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;calcium-mediated signaling;response to amino acid
- Cellular component
- plasma membrane;integral component of plasma membrane;cell surface
- Molecular function
- G protein-coupled receptor activity;signaling receptor activity